[Kulenkampf-Tarnow syndrome, problems of its pathogenesis and treatment].
D000293:Adolescent; D000328:Adult; D001285:Atropine / Q000627:therapeutic use; D001933:Brain Stem / Q000187:drug effects; D002110:Caffeine / Q000627:therapeutic use; D002746:Chlorpromazine / Q000009:adverse effects*; D004809:Ephedrine / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008410:Masticatory Muscles / Q000187:drug effects; D008636:Mesencephalon / Q000187:drug effects; D009120:Muscle Cramp / Q000139:chemically induced*; D012154:Reticular Formation / Q000187:drug effects; D012559:Schizophrenia / Q000188:drug therapy; D012640:Seizures / Q000139:chemically induced* / Q000188:drug therapy / Q000209:etiology; D014313:Trismus / Q000139:chemically induced
D002110:Caffeine; D001285:Atropine; D004809:Ephedrine; D002746:Chlorpromazine
Sindrom Kulenkampfa-Tarnova, voprosy patogeneza i lecheniia.